By Dr. Eric Grigsby Dr. Eric Grigsby, CEO and Found of Neurovations Diabetic peripheral neuropathy is a debilitating, progressive neurologic disorder that affects about 30% of adults with diabetes. Spinal cord stimulation is a newer option for addressing moderate to severe pain related to the condition. Red the Story on Endorcrinetoday The post Spinal cord […]
Neurovations Awarded 6.9 million-Dollar Grant for Groundbreaking Educational Pain Research Program
NIH HEAL Initiative: Coordinating Center for National Pain Scientists Career Development Grant awarded to Neurovations Education Division CEO and Founder of Neurovations, Dr. Eric Grigsby NAPA, Calif., Oct. 13, 2022 /PRNewswire/ — Dr. Eric Grigsby, Founder and CEO of Neurovations, announced that Neurovations Education is the recipient of a 6.9 million-dollar grant from the Helping to End Addiction Long-term Initiative®, […]
NAPA, Calif., Sept. 28, 2022 /PRNewswire/ — Neurovations now offers transcranial magnetic stimulation (TMS) for the treatment of Major Depressive Disorder (MDD) — making it the first mental health provider of TMS Therapy in Napa Valley where mental health services are in high demand. TMS is used to activate areas of the brain that are underactive in depression. The addition of […]
Dr. Katalin Karikó, co-inventor of the modified mRNA technology used in vaccines to prevent COVID-19 infection, keynotes the Napa Pain Conference August 23. 2022 Napa, CALIF, – Approximately 600 top scientists, interventional pain physicians, policy-makers, researchers and innovators gathered to attend the 29th Napa Pain Conference (NPC) in downtown Napa. “This year, we were honored […]
Founder Dr. Eric Grigsby reveals new hybrid event to share knowledge broadly Tuesday, September 14, 2021 The Napa Pain Conference hosted its twenty-eighth meeting in downtown Napa this past week, making it the oldest running pain conference in the Western United States. Experts in pain management gathered including Nobel Laureate Elizabeth Blackburn, PhD as keynote […]
NeuroTech Reports by James Cavuoto, editor and publisher Several hundred pain clinicians attended the 28th Napa Pain Conference in Napa, CA earlier this month. The event, produced by Neurovations Education, took place at the Culinary Institute of America’s Copia facility, with participation from online attendees. Featured presenters at the event included Daniel Carr, professor emeritus […]
CEO and Founder Dr. Eric Grigsby Founder Dr. Eric Grigsby reveals new hybrid event to share knowledge broadly Tuesday, September 14, 2021 The Napa Pain Conference hosted its twenty-eighth meeting in downtown Napa this past week, making it the oldest running pain conference in the Western United States. Experts in pain management gathered including Nobel […]
Completion of enrollment for the Phase 2b study in osteoarthritis of the knee Clinical data presented at OARSI provides support for osteoarthritis program First patient dosed in the Phase 1/2a study in neuropathic pain NEW YORK–(BUSINESS WIRE)–Xalud Therapeutics, a clinical-stage biotechnology company developing novel non-viral gene therapies to treat pathologic inflammation through immune modulation, today […]
Device may allow surgeons in low-income countries to correct rare, often fatal birth defect. Published May 05, 2021 under Education News Written by Michael Penn A team of Duke students that is working to make life-saving surgery possible for infants with a rare birth defect has won the top prize at the 2021 Bay Area Global […]
CEO and Founder Dr. Eric Grigsby focuses on what chronic pain really means.
Monday, December 14, 2020 – The Yountville Chamber of Commerce, in partnership with N3 Laboratories, CORE and the Town of Yountville, is now offering COVID-19 testing every Wednesday at the Yountville Community Center from 9:00 a.m. to 12:00 noon. The Yountville Community Center is located at 6516 Washington St. in downtown Yountville. Tests are administered […]